JB
Therapeutic Areas
Lexeo Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LX2006 | Friedreich's Ataxia Cardiomyopathy | Phase 2 |
| LX1001 | APOE4-Associated Alzheimer's Disease | Phase 1/2 |
| LX2020 | Arrhythmogenic Cardiomyopathy (PKP2-associated) | Phase 1/2 |
| LX2021 | Desmoplakin (DSP)-Associated Cardiomyopathy | Preclinical |
| LX2022 | Hypertrophic Cardiomyopathy (MYBPC3-associated) | Preclinical |